[Malignant pheochromocytoma: blood pressure controlled by labetalol].
作者信息
Sugano O, Hirano J, Hirano K, Kubota Y, Numasawa K, Kawamura S
出版信息
Nihon Hinyokika Gakkai Zasshi. 1984 Mar;75(3):523-7.
PMID:6471663
Abstract
摘要
相似文献
1
[Malignant pheochromocytoma: blood pressure controlled by labetalol].[恶性嗜铬细胞瘤：拉贝洛尔控制血压]
Nihon Hinyokika Gakkai Zasshi. 1984 Mar;75(3):523-7.
2
Labetalol in the treatment of a patient with phaechromocytoma: a case report.拉贝洛尔治疗嗜铬细胞瘤患者：一例报告
Br J Clin Pharmacol. 1979;8(Suppl 2):141S-142S.
3
[Pheochromocytoma treated with combined alpha-beta blockader].[联合使用α-β受体阻滞剂治疗嗜铬细胞瘤]
Lakartidningen. 1979 Jun 6;76(23):2248-50.
4
[Clinical effects of labetalol on pheochromocytoma].拉贝洛尔对嗜铬细胞瘤的临床疗效
Horumon To Rinsho. 1983 Feb;31(2):183-92.
5
[Labetalol in the intraoperative control of pheochromocytoma].
Lijec Vjesn. 1983 Jul-Aug;105(7-8):304-6.
6
Use of labetalol during anesthesia for pheochromocytoma removal.在嗜铬细胞瘤切除术中麻醉期间使用拉贝洛尔。
Acta Anaesthesiol Belg. 1983 Dec;34(4):233-40.
7
[Clinical effects of labetalol in 21 patients with phaeochromocytoma (author's transl)].拉贝洛尔对21例嗜铬细胞瘤患者的临床疗效（作者译）
Horumon To Rinsho. 1981 Apr;29(4):515-22.
8
Treatment of phaeochromocytoma and of clonidine withdrawal hypertension with labetalol.用拉贝洛尔治疗嗜铬细胞瘤和可乐定撤药后高血压。
Br J Clin Pharmacol. 1976 Aug;3(4 Suppl 3):809-15.
9
Effect of labetalol on blood pressure and plasma catecholamine concentrations in patients with phaeochromocytoma.拉贝洛尔对嗜铬细胞瘤患者血压和血浆儿茶酚胺浓度的影响。
Br Med J. 1980 May 31;280(6227):1300-1. doi: 10.1136/bmj.280.6227.1300-a.
10
Labetalol: the nineteen-eighties.拉贝洛尔：20世纪80年代。
Br J Clin Pharmacol. 1982 Jun;13(1 Suppl):137S-141S. doi: 10.1111/j.1365-2125.1982.tb01903.x.
Zotero 插件